Clinical Trial: A Study to Evaluate the Safety, Tolerability, PK and Preliminary Efficacy of HX15001 Combined With Etrasimod in Moderate-severe Ulcerative Colitis

U.S., Aug. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07768254) titled 'A Study to Evaluate the Safety, Tolerability, PK and Preliminary Efficacy of HX15001 Combined With Etrasimod in Moderate-severe Ulcerative Colitis' on Aug. 07.

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of HX15001 injection combined with Etrasimod tablets in participants with moderately to severely active ulcerative colitis (UC).

Study Start Date: Sept. 09

Study Type: INTERVENTIONAL

Condition: Colitis, Ulcerative

Intervention: DRUG: Biological: HX15001

Dose 1: HX15001

DRUG: Biological: HX15001

Dose 2: HX15001

DRUG: Biological: HX15001

Dose 3...